Literature DB >> 1533757

Interleukin-2 receptor positive cells in human decidua during the first trimester of pregnancy and their association with macrophages.

E Kovacs1, M Meichsner-Frauli, H Ludwig.   

Abstract

Maternal immune rejection of the fetus could sometimes be the cause of unexplained recurrent spontaneous abortion. Components of the T cell-mediated immunity were investigated in the first trimester of pregnancy in women having spontaneous abortion and compared to those with normal pregnancy having a termination on social grounds. Interleukin 2 (IL-2) had no proliferative effect on the trophoblasts of chorionic villi and there were also no IL-2 receptors in these cells. However IL-2 receptor positive cells were found in the decidua in 7 out of 24 women with normal pregnancy and in 12 out of 18 with spontaneous abortion. A high density of macrophages showed an association with IL-2 receptors in both groups. There were no differences with respect to T-cytotoxic cells and T-helper cells in cases of normal pregnancy (with and without IL-2 receptor positive cells), whereas in women having spontaneous abortion we found lower densities of T-helper and T-cytotoxic cells in those without IL-2 receptors than in those with IL-2 receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533757     DOI: 10.1007/bf02759917

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  12 in total

1.  The T-lymphocyte population in first-trimester human decidua does not express the interleukin-2 receptor.

Authors:  J N Bulmer; P M Johnson
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

2.  The interleukin 2 gene is expressed in the syncytiotrophoblast of the human placenta.

Authors:  K D Boehm; M F Kelley; J Ilan; J Ilan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  PGE2-mediated immunosuppression by first trimester human decidual cells blocks activation of maternal leukocytes in the decidua with potential anti-trophoblast activity.

Authors:  R S Parhar; S Yagel; P K Lala
Journal:  Cell Immunol       Date:  1989-04-15       Impact factor: 4.868

4.  Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses.

Authors:  J Shaw; B Caplan; V Paetkau; L M Pilarski; T L Delovitch; I F McKenzie
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

5.  Analysis of the two-signal requirement for precursor cytolytic T lymphocyte activation using H-2Kk in liposomes.

Authors:  S H Herrmann; O Weinberger; S J Burakoff; M F Mescher
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

6.  Some effects of immunological factors on gestation in mice.

Authors:  D A James
Journal:  J Reprod Fertil       Date:  1967-10

7.  The immunostimulatory effect of T cells and T cell lymphokines on murine fetally derived placental cells.

Authors:  I Athanassakis; R C Bleackley; V Paetkau; L Guilbert; P J Barr; T G Wegmann
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

8.  Interleukin 2: the molecule and its function.

Authors:  R J Robb
Journal:  Immunol Today       Date:  1984-07

9.  IL2-like material is present in human placenta and amnion.

Authors:  P Soubiran; J P Zapitelli; L Schaffar
Journal:  J Reprod Immunol       Date:  1987-11       Impact factor: 4.054

10.  T-T-cell interactions during the vitro cytotoxic allograft responses. I. Soluble products from activated Lyl+ T cells trigger autonomously antigen-primed Ly23+ T cells to cell proliferation and cytolytic activity.

Authors:  H Wagner; M Röllinghoff
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  1 in total

1.  Transcriptomic analysis of vitamin D responses in uterine and peripheral NK cells.

Authors:  J A Tamblyn; L E Jeffery; R Susarla; D M Lissauer; S L Coort; A Muñoz Garcia; K Knoblich; A L Fletcher; J N Bulmer; M D Kilby; M Hewison
Journal:  Reproduction       Date:  2019-08       Impact factor: 3.906

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.